Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

VMD issues product defect recall alert
The recall affects batches of Carprieve 5% w/v Small Animal Solution for Injection.

Recall is a precautionary measure owing to higher than usual impurities.

The Veterinary Medicines Directorate (VMD) has issued a product defect recall alert for Carprieve 5% w/v Small Animal Solution for Injection, manufactured by Norbrook Laboratories Ltd.

A statement reads: 'We wish to make veterinary surgeons aware that Norbrook Laboratories Ltd have initiated a Class 2 recall to veterinarian level for the product Carprieve 5% w/v Small Animal Solution for Injection. This is as a precautionary measure due to higher than usual impurities.

'A health hazard assessment has been completed by the company veterinary surgeon. This concludes that any risk to animal and human health is likely to be low and no greater than expected for this product under normal conditions, as described on the product labelling.'

The recall affects the following batch numbers:

0265-90 
0302-90 
0246-90 
0112-90 
0295-90 
9053-91 
9103-91

The statement continues: 'Norbrook Laboratories Ltd are contacting veterinary surgeons to examine inventory immediately and quarantine products subject to this recall.'

For further information regarding the recall contact Gary Mckee on +44 2830 264435 or email gary.mckee@norbrook.co.uk 

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.